Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Adductor Canal Nerve Blocks: Basal vs Bolus
NCT02219438Phase 4Completed
- Sponsor
- University of California, San Diego
- Start
- Aug 2014
- Primary completion
- Dec 2014
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by University of California, San Diego. Primary endpoint: Tolerance to Cutaneous Electrical Current at 8 hours. Started Aug 2014; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02219438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02219438.